In this study the investigators examine the safety and efficacy of Keyhole-limpet-hemocyanin
in patients with chronic hepatitis c infection and liver cirrhosis. The investigators
hypothesize that administration of keyhole-limpet-hemocyanin reduces the viral load in
patients infected with hepatitis c.